Helius Medical Technologies, Inc.
HSDT
$0.3023
-$0.0214-6.61%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 14.63% | -69.70% | -29.92% | 16.98% | -56.23% |
| Total Other Revenue | 0.00% | 0.00% | -8.33% | 120.00% | 1,000.00% |
| Total Revenue | 13.43% | -64.34% | -28.91% | 21.62% | -52.48% |
| Cost of Revenue | 71.11% | 0.00% | -35.87% | 0.82% | -40.00% |
| Gross Profit | -104.55% | -209.09% | -11.11% | 209.09% | -66.67% |
| SG&A Expenses | 33.46% | 29.78% | -4.36% | -8.39% | -17.03% |
| Depreciation & Amortization | -62.50% | -78.13% | -81.58% | -82.05% | -80.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.93% | 31.37% | -0.66% | -9.44% | -19.35% |
| Operating Income | -38.33% | -35.94% | -1.58% | 10.34% | 15.85% |
| Income Before Tax | -275.89% | -0.63% | 2.18% | -0.88% | 78.61% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -275.89% | -0.63% | 2.18% | -0.88% | 78.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -275.89% | -0.63% | 2.18% | -0.88% | 78.61% |
| EBIT | -38.33% | -35.94% | -1.58% | 10.34% | 15.85% |
| EBITDA | -39.10% | -37.33% | -2.62% | 9.55% | 15.37% |
| EPS Basic | 28.93% | 82.03% | 78.07% | 30.37% | 82.98% |
| Normalized Basic EPS | 29.65% | 81.22% | 78.08% | 30.37% | 82.98% |
| EPS Diluted | 28.95% | 81.97% | 78.08% | 30.33% | 82.98% |
| Normalized Diluted EPS | 29.65% | 81.22% | 78.08% | 30.37% | 82.98% |
| Average Basic Shares Outstanding | 428.93% | 460.14% | 346.16% | 44.89% | 25.66% |
| Average Diluted Shares Outstanding | 428.93% | 460.14% | 346.16% | 44.89% | 25.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
